Separator

ADIA to Infuse $200 Million in Medtech Leader Meril, Valuing Firm at $6.6 Billion

Separator
  • ADIA to invest $200M for ~3% stake in Meril, valuing the medtech giant at $6.6 billion.
  • Meril operates a 100-acre global MedTech campus, serving 150+ countries.
  • Backed by Warburg Pincus and ADIA, Meril strengthens global expansion and advanced R&D efforts.

A fully owned subsidiary of Abu Dhabi Investment Authority (ADIA) has entered into binding agreements to invest $200 million in Micro Life Sciences Private Limited, the parent company of Meril, which is one of India's leading medical devices companies. The transaction confers ADIA an equity stake of around 3%, valuing Meril's enterprise at $6.6 billion.

The deal is pending regulatory approval from the Competition Commission of India (CCI). On completion, Meril will have the backing of two world-class investors ADIA and Warburg Pincus.

Started by the Bilakhia Group, Meril is recognized for its clinically innovative medical solutions across different specialties like cardiovascular care, structural heart interventions, orthopaedics, endo-surgery, in-vitro diagnostics, and surgical robotics.

Also Read- Zoho Bets Big on AI and Robotics with Kerala Campus & Startup Buyout

Based out of its international headquarters in Vapi, Gujarat, Meril operates a state-of-the-art, fully integrated, and internationally accredited manufacturing and R&D campus spread over 100 acres. The organization has over 13,000 professionals working for it, has a presence through 35+ subsidiaries across the globe, and supplies products to healthcare systems in more than 150 countries.

Meril has a robust in-house research, clinical, and design ecosystem underpinned by more than 200 proprietary technology platforms. It also has 12+ global training academies, through which it trains over 10,000 healthcare professionals every year.

Referring to the investment, Sanjeev Bhatt, Senior Vice President – Strategy at Meril, stated:

"ADIA's investment reflects its faith in our long-term strategy and worldwide growth prospects. This funding will enable us to accelerate faster, hire world-class professionals, and increase research and clinical strength, all with the purpose of improving human health through innovative medical solutions."

Founded in 1976, the Abu Dhabi Investment Authority is one of the most well-known sovereign wealth funds globally. It invests on behalf of the Government of Abu Dhabi with a long-term value creation strategy based on geographies.